Carnitine: A False Dawn in the Treatment of Muscle Weakness in End-Stage Renal Failure Patients?

Publisher： Karger

E-ISSN： 1660-2110|97|2|c33-c34

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.97, Iss.2, 2004-11, pp. : c33-c34

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Management of end-stage renal failure

By Al-Mosawi Aamir Jalal  

Therapy, Vol. 3, Iss. 2, 2006-03 ,pp. : 307-309

Future Medicine

Access to resources Recommend Favorite

Fabry Disease in Patients with End-Stage Renal Failure: The Potential Benefits of Screening

By  

Nephron Clin Pract, Vol. 101, Iss. 1, 2005-05 ,pp. : c33-c38

Karger

Access to resources Recommend Favorite

Effects of Carnitine Supplementation on Muscle Metabolism by the Use of Magnetic Resonance Spectroscopy and Near-Infrared Spectroscopy in End-Stage Renal Disease

By  

Nephron Clin Pract, Vol. 97, Iss. 2, 2004-11 ,pp. : c41-c48

Karger

Access to resources Recommend Favorite

Diagnosis and Treatment of Low Testosterone among Patients with End‐Stage Renal Disease

By  

SEMINARS IN DIALYSIS, Vol. 28, Iss. 3, 2015-05 ,pp. : 259-265

John Wiley & Sons Inc

Access to resources Recommend Favorite

Optimising Treatment of End-Stage Renal Disease in the Elderly

By  

Nephron Clin Pract, Vol. 124, Iss. 3-4, 2014-01 ,pp. : 202-208

Karger

Access to resources Recommend Favorite